12 Best Marijuana Stocks to Buy According to Analysts

Page 2 of 10

9. Cronos Group Inc. (NASDAQ:CRON)

Analysts’ Upside Potential as of September 5: 16.53%

Cronos Group Inc. (NASDAQ:CRON) announced $33.5 million in net revenue for the second quarter of 2025, a 21% jump year over year. The growth was due to booming cannabis flower sales in Israel and international markets, Cronos GrowCo consolidation, and stronger Canadian extract sales. The gross profit increased from $8.2 million in the second quarter of 2024 to $14.5 million. Adjusted EBITDA climbed by $12.7 million from the previous year to $1.7 million. Cronos reported a net loss of $38.5 million despite sales growth and efficiency benefits.

Cronos Group Inc. (NASDAQ:CRON)’s PEACE NATURALS® retained its position as Israel’s leading cannabis brand, driving record sales in the country. CEO Mike Gorenstein noted planned flower capacity growth and strong global momentum to alleviate supply limitations in Canada. This quarter’s flower sales brought roughly $2.2 million for Cronos GrowCo. The firm maintains a strong balance sheet with $834 million in cash and no debt, allowing it to support international growth and innovation in brands including Lord Jones® and Spinach®. It is one of the Best Marijuana Stocks.

Page 2 of 10